000227.KS

Yuyu Pharma, Inc. [000227.KS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

000227.KS Stock Summary

Top 10 Correlated ETFs

000227.KS

Top 10 Correlated Stocks

000227.KS

In the News

000227.KS Financial details

Company Rating
-
Market Cap
78.74B
Income
-6.82B
Revenue
137.21B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
318
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
0.67
P/B
-
P/C
-
P/FCF
-5.44
Quick Ratio
-
Current Ratio
1.99
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-420.48
EPS next Y
-
EPS next Q
-
EPS this Y
65.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
8.59%
Revenue Q/Q
1.52%
EPS Q/Q
-59.94%
-
-
-
-
SMA20
10.96%
SMA50
8.04%
SMA100
5.39%
Inst Own
-
Inst Trans
-
ROA
-4%
ROE
-7%
ROC
-
Gross Margin
37%
Oper. Margin
-
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9150.0-21400.0
52W High
-51.07%
52W Low
+14.43%
RSI
56
Rel Volume
0.52
Avg Volume
3.14K
Volume
1.63K
Perf Week
-4.47%
Perf Month
10.91%
Perf Quarter
2.05%
Perf Half Y
2.65%
-
-
-
-
Beta
0.608
-
-
Volatility
194.56%, 685.7%
Prev Close
0%
Price
10470
Change
-0.85%

Something similar

Top by Market Cap
GOOGL
NVD.DE
3V64.DE
BRK-B
0YXG.L
Top Correlated ETFs
139660.KS
Top Correlated Stocks
000225.KS
000970.KS
005745.KS
26490K.KS
009190.KS
Similar Market Cap
6703.T
004080.KS
4694.T
ECL
0019.HK

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 3.14K
  • Market Capitalization 78.74B
  • Employee 318
  • CEO Mr. Wonsang Yu
  • Headquarters Seoul,KR
  • IPO Date 2000-06-20
  • Website https://www.yuyu.co.kr

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.